Besides, CMTM7 can inhibit the growth of esophageal squamous cell carcinoma (ESCC) and non-small cell lung cancer (NSCLC) by suppressing EGFR/AKT signaling [13, 14]. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.